Document:

Predictmedix Inc.: Exhibit 4.7 - Filed by newsfilecorp.com

    

    

    

    

    

    

    

    

    

    ADDENDUM TO THE CONSULTING AGREEMENT

    THIS ADDENDUM IS MADE TO THE CONSULTING AGREEMENT (the "Agreement") effective as of July 1, 2020, (the "Effective Date"), by and between Predictmedix Inc., a Company incorporated in Canada (the "Company"), with registered address at Suite 3000, Kings Street West, TD Centre, North Tower, PO Box 95, Toronto Canada and 2499597 Ontario Inc., a corporation with an address at 141 Codsell Ave, Toronto, ON, M3H 3W5 Canada represented by Rahul Kushwah. (the "Executive").

    Both parties mutually agree to amend clause 4(a) of the said agreement effective September 1, 2020: 

    The new Clause 4(a) effective September 1, 2020 reads as follows:

    4. Compensation.

    (a) Remuneration. During the Services Term, Executive will receive a monthly fee (the "Services Fee") of CAD$6,000. In addition, the executive will be reimbursed $1,500 per month for use of personal vehicle for Company business. The Company will make one cheque payment for $7,500 per month either in name of 2499597 Ontario Inc. or in name of Rahul Kushwah for the services.

    All other terms and conditions of the said agreement are unchanged and binding on both parties

    IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the 4th day of October 2020.

    	 	Predictmedix Inc.
	 	 	 
	 	By:	 /s/ Rakesh Malhotra
	 	 	 
	 	Name:	Rakesh Malhotra
	 	Title:	CFO

     

    	 	Executive (2499597 Ontario Inc.)
	 	 	 
	 	By:	 /s/ Rahul Kushwah
	 	 	 
	 	Name: 	Rahul Kushwah
	 	Title: 	COO

     

     

    

    ADDENDUM # 2 TO THE CONSULTING AGREEMENT

     

    THIS ADDENDUM IS MADE TO THE CONSULTING AGREEMENT (the "Agreement") effective as of May 1, 2021, (the "Effective Date"), by and between Predictmedix Inc., a Company incorporated in Canada (the "Company"), with registered address at Suite 3000, 77 Kings Street West, TD Centre, North Tower, PO Box 95, Toronto Canada and 2499597 Ontario Inc., a corporation with an address at 141 Codsell Ave, Toronto, ON, M3H 3W5 Canada represented by Rahul Kushwah. (the "Executive").

    Both parties mutually agree to amend clause 4(a) of the said agreement which was effective September 1, 2020:

    The amended Clause 4(a) effective May 1, 2021 reads as follows:

    4. Compensation.

    (a) Remuneration. During the Services Term, Executive will receive a monthly fee (the "Services Fee") of CAD$8,500. In addition, the executive will be reimbursed $1,500 per month for use of personal vehicle for Company business. The Company will make one cheque payment for $10,000 per month either in name of 2499597 Ontario Inc. or in name of Rahul Kushwah for the services.

    All other terms and conditions of the said agreement are unchanged and binding on both parties

    IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the 7th day of June 2021. 

    	 	Predictmedix Inc.
	 	 	 
	 	By:	 /s/ Rakesh Malhotra
	 	 	 
	 	 	Rakesh Malhotra
	 	Title:	CFO

     

    	 	Executive (2499597 Ontario Inc.)
	 	 	 
	 	By:	 /s/ Rahul Kushwah
	 	 	 
	 	Name:	Rahul Kushwah
	 	Title:	COOPredictmedix Inc.: Exhibit 4.8 - Filed by newsfilecorp.com

    

    Att. Ref. No.: PMIX001USP

    ASSIGNMENT OF PATENT RIGHTS

    WHEREAS, I, Rahul Kushwah, of 141 Codsell Avenue, Toronto M3H 3W5, Canada, Sheldon Kales, of 464 Old Orchard Grove, Toronto M5M 2G4, Canada, Nandan Mishra, of 1401, Tower B, Purvanchal Royal Park, Sector 137, Nolda 201305, India, and Himanshu Ujjawal Singh,of 1st Floor, 80Begumpur, Shivalik Road, Beampur, Ha, Malviya Nagar 11017, India, made certain new and useful inventions and improvements for which application for United States Letters Patent application, entitled "ARTIFICIAL INTELLIGENCE DRIVEN RAPID TESTING SYSTEM FOR INFECTIOUS DISEASES";

    AND WHEREAS, PredictMedix, Inc., a corporation organized and existing under and by virtue of the laws of the Country of Canada, and having an office and place of business at 77 King Street West, Suite 3000, Toronto M5K 1G8, Canada, (hereinafter "Assignee"), is desirous of acquiring the entire right, title and interest in and to said inventions, improvements, applications, and in and to any Letters Patent to be obtained therefore;

    NOW, THEREFORE, to all whom it may concern, be it known that for good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged, I have sold, assigned, and transferred, and by these presents do sell, assign, and transfer unto said Assignee, its successors or assigns, the entire right, title and interest for all countries in and to all inventions and improvements disclosed in the aforesaid application, and in and to said application, all divisions, continuations, continuations-in-part, or renewals thereof, all Letters Patent which may be granted there from, and all reissues or extensions of such patents, and in and to any and all applications which have been or shall be filed in any foreign countries for Letters Patent for said inventions and improvements, including an assignment of all rights under the provisions of the International Convention, and all Letters Patent of foreign countries which may be granted there from; and I do hereby authorize and request the Commissioner of Patents and Trademarks to issue any and all United States Letters Patent for the aforesaid inventions and improvements to the said Assignee as the assignee of the entire right, title and interest in and to the same, for the use of the said Assignee, its successors and assigns.

    AND, for the aforementioned consideration, I do hereby agree that I and my executors and legal representatives will make, execute, and deliver any and all other instruments in writing including any and all further application papers, affidavits, assignments, and other documents, and will communicate to said Assignee, its successors and representatives all facts known to us relating to said improvements and the history thereof and will testify in all legal proceedings and generally do all things which may be necessary or desirable more effectually to secure to and vest in said Assignee, its successors or assigns the entire right, title and interest in and to the said improvements, inventions, applications, Letters Patent, rights, titles, benefits, privileges and advantages hereby sold, assigned and conveyed, or intended so to be.

    AND, furthermore, I covenant and agree with said Assignee, its successors and assigns, that I have made no assignment, grant, mortgage, license, or other agreement affecting the rights and property herein conveyed to any other parties, and that I possess the full right to convey the same as expressed herein.

    

    Docket No: PMIX001USP
Serial Number : 63/012,510
Filing Date :  April 20, 2020

    Effective as of the _6____ day of ____July________________, 2020___.

    	 	By: 	/s/ Rahul Kushwah
	 	 	Rahul Kushwah

    Effective as of the __6___ day of _____July_______________, 2020___.

    	 	By: 	/s/ Sheldon Kales
	 	 	Sheldon Kales

    Effective as of the _6____ day of ____July________________, 2020___.

    	 	By: 	/s/ Nandan Mishra
	 	 	Nandan Mishra

    Effective as of the _6____ day of ___July_________________, 2020___.

    	 	By: 	/s/ Himanshu Ujjawal Singh
	 	 	Himanshu Ujjawal SinghPredictmedix Inc.: Exhibit 4.9 - Filed by newsfilecorp.com

    

    Att. Ref. No.: PMIX002USP, PIXM003USP

    ASSIGNMENT OF PATENT RIGHTS

    WHEREAS, I, Rajiv Muradia, of 111 Echo Drive, Unit 8, Ottawa, Ontario K1S 5K8, Canada, made certain new and useful inventions and improvements for which the following applications for United States Letters Patent have been filed

    • Application serial number 63048131, entitled "SYSTEM AND METHOD TO AUTOMATICALLY RECOMMEND AND ADAPT A TREATMENT REGIME FOR PATIENTS" filed 05-JUL-2020; and

    • Application serial number 63048152, entitled "SYSTEM AND METHOD TO MANAGE A REWARDS PROGRAM FOR PATIENT TREATMENT PROTOCOLS" filed 05- JUL-2020.

    AND WHEREAS, PredictMedix, Inc., a corporation organized and existing under and by virtue of the laws of the Country of Canada, and having an office and place of business at 77 King Street West, Suite 3000, Toronto M5K 1G8, Canada, (hereinafter "Assignee"), is desirous of acquiring the entire right, title and interest in and to the subject matter contained in said applications, including any inventions, improvements, related applications, and in and to any Letters Patent to be obtained therefore;

    NOW, THEREFORE, to all whom it may concern, be it known that for good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged, I have sold, assigned, and transferred, and by these presents do sell, assign, and transfer unto said Assignee, its successors or assigns, the entire right, title and interest for all countries in and to all inventions and improvements disclosed in the aforesaid applications, and in and to said applications, all divisions, continuations, continuations-in-part, or renewals thereof, all Letters Patent which may be granted there from, and all reissues or extensions of such patents, and in and to any and all applications which have been or shall be filed in any foreign countries for Letters Patent for said inventions and improvements, including an assignment of all rights under the provisions of the International Convention, and all Letters Patent of foreign countries which may be granted there from; and I do hereby authorize and request the Commissioner of Patents and Trademarks to issue any and all United States Letters Patent for the aforesaid inventions and improvements to the said Assignee as the assignee of the entire right, title and interest in and to the same, for the use of the said Assignee, its successors and assigns.

    AND, for the aforementioned consideration, I do hereby agree that I and my executors and legal representatives will make, execute, and deliver any and all other instruments in writing including any and all further application papers, affidavits, assignments, and other documents, and will communicate to said Assignee, its successors and representatives all facts known to us relating to said improvements and the history thereof and will testify in all legal proceedings and generally do all things which may be necessary or desirable more effectually to secure to and vest in said Assignee, its successors or assigns the entire right, title and interest in and to the said improvements, inventions, applications, Letters Patent, rights, titles, benefits, privileges and advantages hereby sold, assigned and conveyed, or intended so to be.

    

    Docket No: PMIX002USP

    Filing Date : July 5, 2020

    AND, furthermore, I covenant and agree with said Assignee, its successors and assigns, that I have made no assignment, grant, mortgage, license, or other agreement affecting the rights and property herein conveyed to any other parties, and that I possess the full right to convey the same as expressed herein.

    Effective as of the 6th day of July, 2020.

    	 	By: /s/ Rajiv Muradia 
 Rajiv Muradia

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]